High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies

Pseudomyxoma peritonei (PMP) is a rare, slow-growing cancer with few efficacious treatment options in unresectable cases. Mutations in the KRAS and GNAS oncogenes are common, but the reported frequencies vary greatly, most likely because of low tumor cellularity in peritoneal tumor samples. With tre...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Torgunrud Annette, Lund-Andersen Christin, Davidson Ben, Nitschke Marcussen Ina Katrine, Larsen Stein G., Dagenborg Vegar, Flatmark Kjersti
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	De Gruyter 2025-12-01
Schriftenreihe:	Pleura and Peritoneum
Schlagworte:	pseudomyxoma peritonei kras mutation gnas mutation oncogenes targeted therapy
Online-Zugang:	https://doi.org/10.1515/pp-2025-0034
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!